Skip to main content
Erschienen in: World Journal of Urology 6/2005

01.12.2005 | Topic Paper

Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries—immunohistochemical distribution and functional significance

verfasst von: Eginhard Waldkirch, Stefan Ückert, Hüseyin Yildirim, Michael Sohn, Udo Jonas, Christian G. Stief, Karl-Erik Andersson, Petter Hedlund

Erschienen in: World Journal of Urology | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Objectives: It has been well established that male erectile dysfunction is frequently associated with vascular diseases. The normal function of cavernous arteries is considered a prerequisite to maintain sufficient blood flow to the trabecular spaces in order to enable penile erection. Contractility of cavernous arteries is regulated by the peripheral autonomic nervous system and endogenous factors released from the endothelial cell layer. A significant increase of blood flow in the central cavernous arteries is the initial event leading to penile tumescence and rigidity. Besides the significance of the nitric oxide/cyclic guanosine monophosphate (cGMP)-mediated mechanisms, the cyclic AMP (cAMP) signalling pathway is also involved in the regulation of tone of the erectile tissue, and interactions between cGMP- and cAMP-mediated mechanisms have been demonstrated. The aim of the present study was to investigate by means of immunohistochemistry the presence of the phosphodiesterase (PDE) isoenzymes 3, 4 (cAMP-specific PDEs) and 5 (cGMP-specific PDE) in thin sections of human central cavernous arteries (HCA) and their functional significance in the mechanism of vessel tone regulation. Methods: Functional experiments were performed using circular segments of HCA and strip preparations of the human corpus cavernosum (HCC). Relaxant effects induced by the cumulative addition of the PDE inhibitors milrinone (PDE3 inhibitor), rolipram (PDE4 inhibitor) and sildenafil (PDE5 inhibitor; 0.01, 0.1, 1 and 10 M) were studied in preparations of HCA and HCC challenged by 1 M norepinephrine (NE). Moreover, immunohistochemistry was carried out in order to evaluate the expression of PDE3, PDE4 and PDE5 in thin sections of HCA. Results: Milrinone, rolipram and sildenafil dose-dependently reversed the NE-induced tension of the isolated vascular segments and HCC strips with sildenafil being the most effective drug. Neither rolipram nor milrinone reached an EC50 value. Abundant immunoreactivities specific for PDE3, PDE4 and PDE5 were observed in the entire smooth musculature of the wall of HCA and resistance arteries. In addition, immunoreactivity for PDE4 was also detected in the cytoplasm of endothelial cells lining the cavernous arteries. Conclusions: The cGMP-dependent relaxation of cavernous arteries is not only dependent on the normal function of the peripheral autonomic nervous system but also on the functional integrity of the vascular endothelium. The expression of the cGMP-specific PDE5 and the ability of the PDE5 inhibitor sildenafil to reverse the adrenergic tension of isolated segments of HCA underline the important role of the NO/cGMP pathway in the control of smooth muscle tone of human trabecular smooth musculature and penile cavernous arteries. Our results also suggest a significance of the cAMP-dependent signaling mechanisms in the regulation of tension of central HCAs. The present findings are also in support of the hypothesis of interactions between the cGMP- and cAMP-mediated signaling pathways in HCAs. Further investigations are indicated in order to outline potential differences between central HCAs and helicine resistance arteries. This may help to understand better the relations between structural and functional changes in the penile erectile tissue in patients with cardiovascular diseases and endothelial dysfunction.
Literatur
1.
Zurück zum Zitat Andersson KE, Wagner G (1995) Physiology of penile erection. Physiol Rev 75:191–236PubMed Andersson KE, Wagner G (1995) Physiology of penile erection. Physiol Rev 75:191–236PubMed
2.
Zurück zum Zitat Wagner G, Willis EA, Bro-Rasmussen F, Nielsen MH (1982) New theory on the mechanism of erection involving hitherto undescribed vessels. Lancet:416–418 Wagner G, Willis EA, Bro-Rasmussen F, Nielsen MH (1982) New theory on the mechanism of erection involving hitherto undescribed vessels. Lancet:416–418
3.
Zurück zum Zitat Banya Y, Ushiki T, Takagane H, Aoki H, Kubo T, Ohhori T, Die C (1989) Two circulatory routes within the human corpus cavernosum penis: A scanning electron microscopic study of corrosion casts. J Urol 142:879–883PubMed Banya Y, Ushiki T, Takagane H, Aoki H, Kubo T, Ohhori T, Die C (1989) Two circulatory routes within the human corpus cavernosum penis: A scanning electron microscopic study of corrosion casts. J Urol 142:879–883PubMed
4.
Zurück zum Zitat Montorsi F, Sarteschi M, Maga T, Guazzoni G, Fabris GF, Rigatti P, Pizzini G, Miani A (1998) Functional anatomy of cavernous helicine arteries in potent subjects. J Urol 159:808–810CrossRefPubMed Montorsi F, Sarteschi M, Maga T, Guazzoni G, Fabris GF, Rigatti P, Pizzini G, Miani A (1998) Functional anatomy of cavernous helicine arteries in potent subjects. J Urol 159:808–810CrossRefPubMed
5.
Zurück zum Zitat Hedlund P, Alm P, Andersson KE (1999) NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br J Pharmacol 127:349–360CrossRefPubMed Hedlund P, Alm P, Andersson KE (1999) NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br J Pharmacol 127:349–360CrossRefPubMed
6.
Zurück zum Zitat Hedlund P, Ny L, Alm P, Andersson KE (2000) Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase. J Urol 164:868–875CrossRefPubMed Hedlund P, Ny L, Alm P, Andersson KE (2000) Cholinergic nerves in human corpus cavernosum and spongiosum contain nitric oxide synthase and heme oxygenase. J Urol 164:868–875CrossRefPubMed
7.
Zurück zum Zitat Segarra G, Medina P, Domenech C, Martinez Leon JB, Vila JM, Aldasoro M, Lluch S (1998) Neurogenic contraction and relaxation of human penile deep dorsal vein. Br J Pharmacol 124:788–794CrossRefPubMed Segarra G, Medina P, Domenech C, Martinez Leon JB, Vila JM, Aldasoro M, Lluch S (1998) Neurogenic contraction and relaxation of human penile deep dorsal vein. Br J Pharmacol 124:788–794CrossRefPubMed
8.
Zurück zum Zitat Simonsen U, Prieto D, Sanez de Tejada I, Garcia-Sacristan A (1995) Involvement of nitric oxide in the non-adrenergic non-cholinergic neurotransmission of horse deep penile arteries: role of charybdotoxin-sensitive K(+)-channels. Br J Pharmacol 116:2582–2590PubMed Simonsen U, Prieto D, Sanez de Tejada I, Garcia-Sacristan A (1995) Involvement of nitric oxide in the non-adrenergic non-cholinergic neurotransmission of horse deep penile arteries: role of charybdotoxin-sensitive K(+)-channels. Br J Pharmacol 116:2582–2590PubMed
9.
Zurück zum Zitat Simonsen U, Prieto D, Delgado JA, Hernandez M, Resel L, Saenz de Tejada I, Garcia-Sacristan A (1997) Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clin Sci (Colch) 92:269–275 Simonsen U, Prieto D, Delgado JA, Hernandez M, Resel L, Saenz de Tejada I, Garcia-Sacristan A (1997) Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries. Clin Sci (Colch) 92:269–275
10.
Zurück zum Zitat Andersson KE (2001) Pharmacology of penile erection. Pharmacol Rev 53:417–450PubMed Andersson KE (2001) Pharmacology of penile erection. Pharmacol Rev 53:417–450PubMed
11.
Zurück zum Zitat Gruetter CA, Kadowitz PJ, Ignarro LJ (1981) Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol 59:150–156PubMed Gruetter CA, Kadowitz PJ, Ignarro LJ (1981) Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol 59:150–156PubMed
12.
Zurück zum Zitat Polson JB, Strada SJ (1996) Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annu Rev Pharmacol Toxicol 36:403–427CrossRefPubMed Polson JB, Strada SJ (1996) Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annu Rev Pharmacol Toxicol 36:403–427CrossRefPubMed
13.
Zurück zum Zitat Francis SH, Turko IV, Corbin JD (2001) Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucl Acid Res Mol Biol 65:1–52CrossRef Francis SH, Turko IV, Corbin JD (2001) Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucl Acid Res Mol Biol 65:1–52CrossRef
14.
Zurück zum Zitat Goldstein I, Lue TF, Padma-NathanH, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1397–1404CrossRefPubMed Goldstein I, Lue TF, Padma-NathanH, Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1397–1404CrossRefPubMed
15.
Zurück zum Zitat Saenz de Tejada I, Anglo J, Cuevas P, Fernandez A, Moncada I, Allona A, Lledo E, Körschem HG, Niewöhner U, Hanning H, Pages E, Bischoff E (2001) The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Int J Impot Res 13:282–290CrossRefPubMed Saenz de Tejada I, Anglo J, Cuevas P, Fernandez A, Moncada I, Allona A, Lledo E, Körschem HG, Niewöhner U, Hanning H, Pages E, Bischoff E (2001) The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil. Int J Impot Res 13:282–290CrossRefPubMed
16.
Zurück zum Zitat Eardly J, Cartledge J (2002) Tadalafil (CIALIS™) for men with erectile dysfunction. Int J Clin Pract 56:300–304PubMed Eardly J, Cartledge J (2002) Tadalafil (CIALIS™) for men with erectile dysfunction. Int J Clin Pract 56:300–304PubMed
17.
Zurück zum Zitat Küthe A, Wiedenroth A, Mägert HJ, Ückert S, Forssmann WG, Stief CG, Jonas U (2001) Expression of different phosphodiesterase genes in human cavernous smooth muscle. J Urol 165:280–283CrossRefPubMed Küthe A, Wiedenroth A, Mägert HJ, Ückert S, Forssmann WG, Stief CG, Jonas U (2001) Expression of different phosphodiesterase genes in human cavernous smooth muscle. J Urol 165:280–283CrossRefPubMed
18.
Zurück zum Zitat Hedlund P, Alm P, Ekstrom P, Fahrenkrug J, Hannibal J, Hedlund H, Larsson B, Andersson KE (1995) Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum. Br J Pharmacol 116:2258–2266PubMed Hedlund P, Alm P, Ekstrom P, Fahrenkrug J, Hannibal J, Hedlund H, Larsson B, Andersson KE (1995) Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum. Br J Pharmacol 116:2258–2266PubMed
19.
Zurück zum Zitat Stief CG, Ückert S, Becker AJ, Harringer W, Truss MC, Forssmann WG, Jonas U (2000) Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology 55:146–150CrossRefPubMed Stief CG, Ückert S, Becker AJ, Harringer W, Truss MC, Forssmann WG, Jonas U (2000) Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology 55:146–150CrossRefPubMed
20.
Zurück zum Zitat Ückert S, Hedlund P, Waldkirch E, Sohn M, Jonas U, Andersson KE, Stief CG (2004) Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol 22(4):261–266CrossRefPubMed Ückert S, Hedlund P, Waldkirch E, Sohn M, Jonas U, Andersson KE, Stief CG (2004) Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol 22(4):261–266CrossRefPubMed
21.
Zurück zum Zitat Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S (2005) Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 48:512–518CrossRefPubMed Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S (2005) Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 48:512–518CrossRefPubMed
22.
Zurück zum Zitat Kuhn FE, Mohler ER et al (1991) Effects of high density lipoprotein on acetylcholine induced coronary vasoreactivity. Am J Cardiol 68:1425CrossRefPubMed Kuhn FE, Mohler ER et al (1991) Effects of high density lipoprotein on acetylcholine induced coronary vasoreactivity. Am J Cardiol 68:1425CrossRefPubMed
23.
Zurück zum Zitat Quyyumi AA, Dakak N, Andrews NP et al (1995) Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis. J Clin Invest 95:1747PubMed Quyyumi AA, Dakak N, Andrews NP et al (1995) Nitric oxide activity in the human coronary circulation: Impact of risk factors for coronary atherosclerosis. J Clin Invest 95:1747PubMed
24.
Zurück zum Zitat Janssen SP, Shimouchi A, Quertermous T et al (1992) Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor nitric oxide synthase. J Biol Chem 267:14519PubMed Janssen SP, Shimouchi A, Quertermous T et al (1992) Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor nitric oxide synthase. J Biol Chem 267:14519PubMed
25.
Zurück zum Zitat Steudel W, Ichinose F, Huang PL et al (1997) Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81:34PubMed Steudel W, Ichinose F, Huang PL et al (1997) Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res 81:34PubMed
26.
Zurück zum Zitat Simonsen U, Contreras J, Garcia-Sacristan A, Martinez AC (2001) Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries. Eur J Pharmacol 412:155–169CrossRefPubMed Simonsen U, Contreras J, Garcia-Sacristan A, Martinez AC (2001) Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries. Eur J Pharmacol 412:155–169CrossRefPubMed
27.
Zurück zum Zitat Medina P, Segarrra G, Vila JM, Domenech C, Martinez-Leon JB, Lluch S (2000) Effects of sildenafil on human penile blood vessels. Urology 56:539–543CrossRefPubMed Medina P, Segarrra G, Vila JM, Domenech C, Martinez-Leon JB, Lluch S (2000) Effects of sildenafil on human penile blood vessels. Urology 56:539–543CrossRefPubMed
28.
Zurück zum Zitat Hedlund H, Andersson KE (1985) Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery. J Urol 134:1245–1250PubMed Hedlund H, Andersson KE (1985) Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery. J Urol 134:1245–1250PubMed
Metadaten
Titel
Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries—immunohistochemical distribution and functional significance
verfasst von
Eginhard Waldkirch
Stefan Ückert
Hüseyin Yildirim
Michael Sohn
Udo Jonas
Christian G. Stief
Karl-Erik Andersson
Petter Hedlund
Publikationsdatum
01.12.2005
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 6/2005
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-005-0026-2

Weitere Artikel der Ausgabe 6/2005

World Journal of Urology 6/2005 Zur Ausgabe

Invited editorial

Editorial

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.